

HTG Molecular Diagnostics develops assays and reagent systems for gene expression analysis. Among its major competitors, HTG Molecular Diagnostics is ranked in 4th place for NPS while Audentes Therapeutics is 1st, and 23andMe is 2nd.Their current market cap is $1.73M